Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 5,070.00
-90.00 (-1.74%)
Last updated: Aug 21, 2026, 3:00 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 121.21 billion as of August 21, 2026. Its market cap has increased by 2.22% in one year.
Market Cap
121.21B
Enterprise Value
265.38B
Revenue
279.55B
Ranking
n/a
PE Ratio
24.03
Stock Price
5,070.00
ChartMarket Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 121.21B, a decrease of -85.20%. That is a compound annual growth rate of -15.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 121.21B | -12.13% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hana Pharm | 149.47B |
| Ilyang Pharmaceutical Co.,Ltd | 148.78B |
| Jeil Pharmaceutical Co.,Ltd | 144.11B |
| Ilsung Is | 142.86B |
| Dongwha Pharm.Co.,Ltd | 141.08B |
| Dong Sung Bio Pharm.Co.,Ltd. | 140.36B |
| Samil Pharmaceutical Co.,Ltd | 132.50B |
| HANDOK | 121.73B |